(Bloomberg) -- Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that ...

Study investigators identified these medications as the formulary medications most frequently ... with continuous enteral nutrition and food, along with recommendations for use and the grade ...

Abbott Laboratories and Reckitt Benckiser Group ... over claims they hid potential risks of their premature-infant formulas. Abbott was down 2.7% at 1:54 p.m. in New York after paring morning ...